• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Skanska Expands Hospital in San Antonio, Texas, USA, for USD 95M, About SEK 960m

Share:

January 2, 2023

Skanska has signed a contract with CHRISTUS Health for an expansion to Christus Santa Rosa Hospital-Westover Hills Hospital in San Antonio, Texas, USA. The contract is worth USD 95M, about SEK 960M, which will be included in the US order bookings for the fourth quarter of 2022.

The project consists of a five-level cast in place concrete tower addition at the hospital, approximately 50,000 square meters of new construction with a minor renovation. The project will be completed in three phases including a new surface parking, a new bed tower addition, and a partial renovation of the existing first floor.

Construction is slated to begin in January 2023 and expected to reach completion in February 2025.

Source: Biospace

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Evaluating Pharma Amid COVID-19Evaluating Pharma Amid COVID-19
  • Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition CorpVisiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp
  • Celgene pledges to limit price hikes—or does it?Celgene pledges to limit price hikes—or does it?
  • Predicting Drug Safety Through Systems ToxicologyPredicting Drug Safety Through Systems Toxicology
  • Sunniva Inc. Agrees To Sell Its Okanagan Falls Property To CannaPharmaRx, Inc. For CAD $20 MillionSunniva Inc. Agrees To Sell Its Okanagan Falls Property To CannaPharmaRx, Inc. For CAD $20 Million
  • Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin ScienceJupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
  • $15.7 Billion Eclinical Solutions Market Insights, 2020-2027: Focus on ECOA, EDC and CDMS$15.7 Billion Eclinical Solutions Market Insights, 2020-2027: Focus on ECOA, EDC and CDMS
  • Anthem, Inc. Signs Enterprise Licensing Agreement with Castlight HealthAnthem, Inc. Signs Enterprise Licensing Agreement with Castlight Health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications